Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
V A Malov, E A Ubeeva, I P Ubeeva and 2 more
Терапевтический архив · 2019
doi:10.26442/00403660.2019.11.000307 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
HCV infection treatment regimens are viewed from positions of HCV life cycle and replication, effects of NS3/4A protease inhibitors and NS5A/NS5B inhibitors on HCV strain replication. Evolution of HCV treatment regimens from its discovery to modern DAA agents had led to substantial progress although drug resistance poses a new issue to be addressed.
Abstract licence: CC BY-NC-SA
References31
31 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.